Mayo Clinic to sequence genome for thousands in personalized medicine embrace

The Mayo Clinic will sequence the genome for thousands of patients in a major pilot study slated to begin early in 2012 as part of a significant move toward "proactive genomics" and personalized medicine, The Guardian reports. Plans call for linking patients' genetic code to their medical records. Doctors can then tap into this information to prescribe the most effective treatment for each individual person with the least amount of side effects. The plunging price tag for genetic tests has, in part, made the pilot study possible, clinic officials said. Story

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.